Protease homologs

Details Protease homologs Protease homologs

1999-03-26

2001-12-18

Murthy, Ponnathapu Achuta (Department: 1652)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Hydrolase

C435S006120, C435S007100, C435S023000, C435S069100, C435S252300, C536S023200

Reexamination Certificate

active

06331427

ABSTRACT:

FIELD OF THE INVENTION
The invention relates to newly identified polynucleotides having homology to various protease families. The invention also relates to protease polypeptides. The invention further relates to methods using the protease polypeptides and polynucleotides as a target for diagnosis and treatment in protease-mediated disorders. The invention further relates to drug-screening methods using the protease polypeptides and polynucleotides to identify agonists and antagonists for diagnosis and treatment. The invention further encompasses agonists and antagonists based on the protease polypeptides and polynucleotides. The invention further relates to procedures for producing the protease polypeptides and polynucleotides.
BACKGROUND OF THE INVENTION
Proteases are a major target for drug action and development. Accordingly, it is valuable to the field of pharmaceutical development to identify and characterize previously unknown protease nucleic acids and polypeptides. The present invention advances the state of the art by providing previously unidentified human protease sequences.
SUMMARY OF THE INVENTION
It is an object of the invention to identify novel proteases.
It is a further object of the invention to provide novel protease polypeptides that are useful as reagents or targets in protease assays applicable to treatment and diagnosis of protease-mediated disorders.
It is a further object of the invention to provide polynucleotides corresponding to the novel protease polypeptides that are useful as targets and reagents in protease assays applicable to treatment and diagnosis of protease-mediated disorders and useful for producing novel protease polypeptides by recombinant methods.
A specific object of the invention is to identify compounds that act as agonists and antagonists and modulate the expression of the novel proteases.
A further specific object of the invention is to provide compounds that modulate expression of the proteases for treatment and diagnosis of protease-related disorders.
The present invention is based on the discovery of novel nucleic acid molecules that are homologous to protease sequences.
Thus, in one aspect, the invention provides an isolated nucleic acid molecule that comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS: 1-268 and the complements of SEQ ID NOS: 1-268.
In another aspect, the invention provides isolated proteins and polypeptides encoded by nucleic acid molecules of the invention.
In another embodiment, the invention provides an isolated nucleic acid molecule that comprises a nucleotide sequence that is at least about 60% identical, preferably at least about 80% identical, preferably at least about 85% identical, more preferably at least about 90% identical, and even more preferably at least about 95% identical, and most preferably about 98% or more identical to a nucleotide sequence selected from the group consisting of SEQ ID NOS: 1-268 and the complements of SEQ ID NOS: 1-268.
The invention also provides isolated variant polypeptides.
The invention also provides an isolated fragment or portion of any of SEQ ID NOS: 1-268 and the complement of SEQ ID NOS: 1-268. In preferred embodiments, the fragment is useful as a probe or primer, and/or is at least 15, more preferably at least 18, even more preferably 20-25, 30, 50, 100, 200 or more nucleotides in length.
The invention also provides isolated fragments of the polypeptides.
In another embodiment, the invention provides an isolated nucleic acid molecule that hybridizes under high stringency conditions to a nucleotide sequence selected from the group consisting of SEQ ID NOS: 1-268 and the complements of SEQ ID NOS: 1-268.
The invention further provides nucleic acid constructs comprising the nucleic acid molecules described above. In a preferred embodiment, the nucleic acid molecules of the invention are operatively linked to a regulatory sequence.
The invention also provides vectors and host cells for expressing the protease nucleic acid molecules and polypeptides and particularly recombinant vectors and host cells.
The invention also provides methods of making the vectors and host cells and methods for using them to produce the protease nucleic acid molecules and polypeptides.
The invention also provides antibodies or antigen-binding fragments thereof that selectively bind the protease polypeptides and fragments.
The invention also provides methods of screening for compounds that modulate expression or activity of the protease polypeptides or nucleic acid (RNA or DNA).
The invention also provides a process for modulating protease polypeptide or nucleic acid expression or activity, especially using the screened compounds. Modulation may be used to treat conditions related to aberrant activity or expression of the protease polypeptides or nucleic acids.
The invention also provides assays for determining the presence or absence of and level of the protease polypeptides or nucleic acid molecules in a biological sample, including for disease diagnosis.
The invention also provides assays for determining the presence of a mutation in the protease polypeptides or nucleic acid molecules, including for disease diagnosis.
In still a further embodiment, the invention provides a computer readable means containing the nucleotide and/or amino acid sequences of the nucleic acids and polypeptides of the invention, respectively.


REFERENCES:
patent: 5700676 (1997-12-01), Bott et al.
Adams, M.D., et al., 1995, Nature, vol. 377 (Supp.), and GenBank EST Accession No. AA305106, “Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence”, pp. 3-174.*
Franz, T., et al., 1999, Mammalian Genome, vol. 10, “Capn7: A highly divergent vertebrate calpain with a novel C-terminal domain”, pp. 318-321.*
Marra, M., et al., murine EST sequence having GenBank Accession No. 238915, cDNA similar to caplain thiol protease, 494nt.*
Futai, E., et al., SPTREMBL translation of human EST having GenBank accession No. AB028639, “Human and mouse homologues of fungus calpain-like protease, PalB”, EC 3.4.22.17, 813aa.*
Prosite Database Search.

Affiliated with

Also associated with

Rating

Protease homologs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protease homologs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protease homologs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2564942